NeuroOne Medical Technologies Corp has regained compliance with Nasdaq's bid price requirement, cancelling its scheduled hearing, and its stock will remain listed on Nasdaq.
AI Assistant
NEUROONE MEDICAL TECHNOLOGIES CORP
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.